Viewing Study NCT00808418

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-02-09 @ 12:51 PM
Study NCT ID: NCT00808418
Status: COMPLETED
Last Update Posted: 2014-02-03
First Post: 2008-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer
Sponsor: Synta Pharmaceuticals Corp.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None prostate View
None cancer View
None metastatic View
None castration View
None refractory View
None elesclomol View
None sodium View
None docetaxel View
None prednisone View